| CAS ID: | 120081-14-3 |
| Molecular Formula: | C20H33N5O9 |
| Molecular Weight: | 487.5 g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | GORALATIDE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C20H33N5O9/c1-11(27)22-14(10-26)18(31)24-13(9-16(28)29)17(30)23-12(5-2-3-7-21)19(32)25-8-4-6-15(25)20(33)34/h12-15,26H,2-10,21H2,1H3,(H,22,27)(H,23,30)(H,24,31)(H,28,29)(H,33,34)/t12-,13-,14-,15-/m0/s1 | See All |
| InChI Key: | HJDRXEQUFWLOGJ-AJNGGQMLSA-N | |
| Smiles: | CC(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)N1CCCC1C(=O)O | See All |
| Molfile: | Download |
Reference Record 1
| PubMed ID | 18178715 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Cardiac fibrosis |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | |||
| Mechanism | |||
| PubChem: | 65938 |
| ChEMBL: | CHEMBL420741 |